Lab-on-a-chip Market, By Product Type (Reagents & Consumables, Software, IV Needles), By Application (Genomics, Proteomics, Diagnostics and Drug Discovery), By Technology (Microarrays and Microfluidics), By End User (Hospitals, Diagnostic Labs, Academic &

Lab-on-a-chip Market, By Product Type (Reagents & Consumables, Software, IV Needles), By Application (Genomics, Proteomics, Diagnostics and Drug Discovery), By Technology (Microarrays and Microfluidics), By End User (Hospitals, Diagnostic Labs, Academic & Research Institutes and Biotechnology & Pharmaceutical Companies) by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

Advancement in technology and techniques of diagnosing pathogen-based disease are expected to favor the lab-on-a-chip market growth. Due to the miniaturization of biochemical operations, better diagnostic speed, cost efficiency, ergonomics, sensitivity etc. can be achieved through lab-on-a-chip device. The biomedical applications of LoC in different fields such as diagnostics, cellomics, in environmental studies to control the effect of pathogens, to check the food quality, detection of various antibiotic families in raw milk favor the growth of lab-on-a-chip market.
Lab-on-a-chip also helps in early detection of chronic diseases which in turn also reduces mortality rate.
Market Dynamics
Increasing adoption of lab-on-a-chip technology is expected to boost the growth of the lab-on-a-chip market. The trend of single-combined tests over numerous tests for various applications is expected to favor growth of the lab-on-a-chip market. The innovation carried out by manufacturers and researchers is positively impacting this market. For instance, in August 2017, researchers in the engineering and chemistry departments of Brigham Young University in Utah developed a 3D-printed lab-on-a-chip device to achieve true microfluidic flow.
Key features of the study:
This report provides in-depth analysis of the global lab-on-a-chip market, market size (US$ Mn), and compound annual growth rate (CAGR (%) for the forecast period (2022 - 2028), considering 2021 as the base year
It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
This study provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by leading players
It profiles key players in the global lab-on-a-chip market based on the following parameters: company overview, financial performance, product portfolio, geographical presence, key developments, and strategies
Key players covered as a part of this study include Becton, Dickinson And Company, Agilent Technologies Inc., Danaher Corporation, Bio-Rad laboratories, Abbott Laboratories, Hoffman-La Roche Ag, PerkinElmer, Inc., IDEX Corporation, Thermo Fisher Scientific, Inc., Cepheid Inc. and Biacore AB.
Insights from this report would allow marketers and management authorities of companies to make informed decisions with respect to future product launches, governmental initiatives, technological up-gradation, market expansion, and marketing tactics
The global lab-on-a-chip market report caters to various stakeholders in this industry, which include investors, product manufacturers, distributors, and suppliers for global lab-on-a-chip market, research and consulting firms, new entrants, and financial analysts
Detailed Segmentation:
Global Lab-on-a-chip Market, by Product Type:
Reagents & Consumables
Software
Instruments
Global Lab-on-a-chip Market, by Application:
Genomics
Proteomics
Diagnostics
Drug Discovery
Global Lab-on-a-chip Market, by Technology:
Microarrays
Microfluidics
Global Lab-on-a-chip Market, by End User:
Hospitals
Diagnostic Labs
Academic and Research Institutes
Biotechnology and Pharmaceutical Companies
Global Lab-on-a-chip Market, by Region:
North America
By Country:
U.S.
Canada
By Product Type:
Reagents & Consumables
Software
Instruments
By Application:
Genomics
Proteomics
Diagnostics
Drug Discovery
By Technology
Microarrays
Microfluidics
By End User:
Hospitals
Diagnostic Labs
Academic and Research Institutes
Biotechnology and Pharmaceutical Companies
Europe
By Country:
U.K.
Germany
Italy
Spain
France
Russia
Rest of Europe
By Product Type:
Reagents & Consumables
Software
Instruments
By Application:
Genomics
Proteomics
Diagnostics
Drug Discovery
By Technology
Microarrays
Microfluidics
By End User:
Hospitals
Diagnostic Labs
Academic and Research Institutes
Biotechnology and Pharmaceutical Companies

Latin America
By Country:
Brazil
Mexico
Argentina
Rest of Latin America
By Product Type:
Reagents & Consumables
Software
Instruments
By Application:
Genomics
Proteomics
Diagnostics
Drug Discovery
By Technology
Microarrays
Microfluidics
By End User:
Hospitals
Diagnostic Labs
Academic and Research Institutes
Biotechnology and Pharmaceutical Companies
Asia Pacific
By Country:
Australia
India
China
Japan
ASEAN
South Korea
Rest of Asia Pacific
By Product Type:
Reagents & Consumables
Software
Instruments
By Application:
Genomics
Proteomics
Diagnostics
Drug Discovery
By Technology
Microarrays
Microfluidics
By End User:
Hospitals
Diagnostic Labs
Academic and Research Institutes
Biotechnology and Pharmaceutical Companies
Middle East
By Country:
Australia
India
China
Japan
ASEAN
South Korea
Rest of Asia Pacific
By Product Type:
Reagents & Consumables
Software
Instruments
By Application:
Genomics
Proteomics
Diagnostics
Drug Discovery
By Technology
Microarrays
Microfluidics
By End User:
Hospitals
Diagnostic Labs
Academic and Research Institutes
Biotechnology and Pharmaceutical Companies
Africa
By Country/Region:
South Africa
Central Africa
North Africa
By Product Type:
Reagents & Consumables
Software
Instruments
By Application:
Genomics
Proteomics
Diagnostics
Drug Discovery
By Technology
Microarrays
Microfluidics
By End User:
Hospitals
Diagnostic Labs
Academic and Research Institutes
Biotechnology and Pharmaceutical Companies
Company Profiles
Becton, Dickinson And Company *
Company Overview
Product Portfolio
Financial Performance
Recent Highlights
Strategies
Agilent Technologies Inc.
Danaher Corporation.
Bio-Rad laboratories
Abbott Laboratories
Hoffman-La Roche Ag
PerkinElmer, Inc.
IDEX Corporation
Thermo Fisher Scientific, Inc.
Cepheid Inc.
Biacore AB.
“*” marked represents similar segmentation in other categories in the respective section